Announcements Trials

Browse Landscape

Status

No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Conditions

Multiple Myeloma 20 Melanoma 16 Prostatic Neoplasms 15 Neoplasms 15 Recurrence 13 Carcinoma, Non-Small-Cell Lung 13 Leukemia, Myeloid, Acute 12 Glioblastoma 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma 8 Breast Neoplasms 7 Sarcoma 6 Neuroblastoma 6 Lung Neoplasms 6 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Leukemia 6 Glioma 6 Pancreatic Neoplasms 5 Lymphoma, Non-Hodgkin 5 Lambert-Eaton Myasthenic Syndrome 5 Gastrointestinal Stromal Tumors 5 Colorectal Neoplasms 5 Carcinoma, Hepatocellular 5 Triple Negative Breast Neoplasms 4 Neuroendocrine Tumors 4 Liver Neoplasms 4 Hodgkin Disease 4 Carcinoma, Renal Cell 4 Precancerous Conditions 3 Pheochromocytoma 3

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Expanded_access × Lymphangioma × Clear all

NCT03941782 2024-01-11

Compassionate Use of BYL 719 Alpelisib

New Mexico Cancer Research Alliance

No longer available

Lymphangioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡